Page 203 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 203

Disorders of Calcium: Hypercalcemia and Hypocalcemia  193



            577. Torrance AG, Nachreiner R. Human-parathormone  597. Wang W, Li C, Kwon TH, et al. AQP3, p-AQP2, and
                assay for use in dogs: validation, sample handling   AQP2 expression is reduced in polyuric rats with hypercal-
                studies, and parathyroid function testing. Am J Vet Res  cemia: prevention by cAMP-PDE inhibitors. Am J Physiol
                1989;50:1123–7.                                      Renal Physiol 2002;283:F1313–25.
            578. Torrance AG, Nachreiner R. Intact parathyroid hormone  598. Ward DT. Calcium receptor-mediated intracellular signal-
                assay and total calcium concentration in the diagnosis of  ling. Cell Calcium 2004;35:217–28.
                disorders of calcium metabolism in dogs. J Vet Intern  599. Warrell Jr RP, Murphy WK, Schulman P, et al. A
                Med 1989;3:86–9.                                     randomized double-blind study of gallium nitrate com-
            579. Tras B, Maden M, Bas AL, et al. Investigation of biochem-  pared with etidronate for acute control of cancer-related
                ical and haematological side-effects of enrofloxacin in  hypercalcemia. J Clin Oncol 1991;9:1467–75.
                dogs. J Vet Med A Physiol Pathol Clin Med       600. Waser M, Mesaeli N, Spencer C, et al. Regulation of
                2001;48:59–63.                                       calreticulin gene expression by calcium. J Cell Biol
            580. Tripp CD, Bryan JN, Wills TB. Presumptive increase in  1997;138:547–57.
                protein-bound serum calcium in a dog with multiple mye-  601. Wasserman RH. Vitamin D and the intestinal absorption
                loma. Vet Clin Pathol 2008;38(1):87–90.              of calcium and phosphorus. In: Feldman BF, editor. Vita-
            581. Troy GC, Forrester D, Cockburn C, et al. Heterobilharzia  min D. New York: Academic Press; 1997. p. 259–273.
                americana infection and hypercalcemia in a dog: a case  602. Waters CB, Scott-Moncrieff JC. Hypocalcemia in cats.
                report. J Am Anim Hosp Assoc 1987;23:35–40.          Compend Contin Educ 1992;14:497–506.
            582. Tucci J, Hammond V, Senior PV, et al. The role of fetal  603. Watson KE, Abrolat ML, Malone LL, et al. Active serum
                parathyroid hormone-related protein in transplacental  Vitamin D levels are inversely correlated with coronary
                calcium transport. J Mol Endocrinol 1996;17:159–64.  calcifications. Circulation 1997;96:1755–60.
            583. Tuma SN, Mallette LE. Hypercalcemia after nephrectomy  604. Weaver ME, Morrissey J, McConkey Jr C, et al. WR-2721
                in the dog: role of the kidneys and parathyroid glands.  inhibits parathyroid adenylate cyclase. Am J Physiol
                J Lab Clin Med 1983;102:213–9.                       1987;252:E197–E201.
            584. Tweedy CR, Rees GM. Octreotide acetate in the treat-  605. Webb J, Chary P, Northrup N, Almy F. Erythrophagocytic
                ment of hypercalcemia accompanying small cell carci-  multiple myeloma in a cat. Vet Clin Pathol 2008;37
                noma. South Med J 1992;85:561.                       (3):302–7.
            585. Tyrrell CJ, Collinson M, Madsen EL, et al. Intravenous  606. Weir EC, Burtis WJ, Morris CA, et al. Isolation of 16,000-
                pamidronate: infusion rate and safety. Ann Oncol     dalton parathyroid hormone-like proteins from two ani-
                1994;5(Suppl. 7):S27–29.                             mal tumors causing humoral hypercalcemia of malig-
            586. Uehlinger P, Glaus T, Hauser B, et al. Differential diagno-  nancy. Endocrinology 1988;123:2744–51.
                sis of hypercalcemia-a retrospective study of 46 dogs.  607. Weir EC, Norrdin RW, Matus RE, et al. Humoral hyper-
                Schweiz Arch Tierheilkd 1998;140:188–97.             calcemia of malignancy in canine lymphosarcoma. Endo-
            587. Unterer S, Lutz H, Gerber B, et al. Evaluation of an elec-  crinology 1988;122:602–8.
                trolyte analyzer for measurement of ionized calcium and  608. Weisbrode SE, Krakowka S. Canine distemper virus-
                magnesium concentrations in blood, plasma, and serum  associated hypocalcemia. Am J Vet Res 1979;40:147–9.
                of dogs. Am J Vet Res 2004;65:183–7.            609. Welches CD, Scavelli TD, Matthiesen DT, et al. Occur-
            588. Urena P, Frazao JM. Calcimimetic agents: review and  rence of problems after three techniques of bilateral
                perspectives. Kidney Int Suppl 2003;85:S91–6.        thyroidectomy in cats. Vet Surg 1989;18:392–6.
            589. Vaden SL, Levine J, Breitschwerdt EB. A retrospective  610. Weller RE, Theilen GH, Madewell BR. Chemotherapeu-
                case-control of acute renal failure in 99 dogs. J Vet Intern  tic responses in dogs with lymphosarcoma and hypercalce-
                Med 1997;11:58–64.                                   mia. J Am Vet Med Assoc 1982;181:891–3.
            590. Vail DM, Kisseberth WC, Obradovich JE, et al. Assess-  611. Wellington K, Goa KL. Zoledronic acid: a review of its
                ment of potential doubling time (Tpot), argyrophilic  use in the management of bone metastases and
                nucleolar organizer regions (AgNOR), and proliferating  hypercalcaemia of malignancy. Drugs 2003;63:417–37.
                cell nuclear antigen (PCNA) as predictors of therapy  612. Wells AL, Long CD, Hornof WJ, et al. Use of percutane-
                response in canine non-Hodgkin’s lymphoma. Exp       ous  ethanol  injection  for  treatment  of  bilateral
                Hematol 1996;24:807–15.                              hyperplastic thyroid nodules in cats. J Am Vet Med Assoc
            591. Vail DM, Withrow SJ, Schwarz PD, et al. Perianal adeno-  2001;218:1293–7.
                carcinoma in the canine male: a retrospective study of 41  613. Whitfield GK, Dang HT, Schluter SF, et al. Cloning of a
                cases. J Am Anim Hosp Assoc 1990;26:329–34.          functional vitamin D receptor from the lamprey
            592. Walker MC, Schaer M. Percutaneous ethanol treatment of  (Petromyzon marinus), an ancient vertebrate lacking
                hyperthyroidism in a cat. Feline Practice 1998;28:10–2.  a  calcified  skeleton  and  teeth.  Endocrinology
            593. Walker P, Watanabe S, Lawlor P, et al. Subcutaneous  2003;144:2704–16.
                clodronate. Lancet 1996;348:345–6.              614. Willard MD, Schall WD, McCaw DE, et al. Canine
            594. Walker P, Watanabe S, Lawlor P, et al. Subcutaneous  hypoadrenocorticism: report of 37 cases and review of
                clodronate: a study evaluating efficacy in hypercalcemia  39 previously reported cases. J Am Vet Med Assoc
                of  malignancy  and  local  toxicity.  Ann  Oncol    1982;180:59–62.
                1997;8:915–6.                                   615. Williams LE, Gliatto JM, Dodge RK, et al. Carcinoma of
            595. Walser M, Robinson BHB, Duckett Jr JW. The hypercal-  the apocrine glands of the anal sac in dogs: 113 cases
                cemia  of  adrenal  insufficiency.  J  Clin  Invest  (1985-1995). J Am Vet Med Assoc 2003;223:825–31.
                1963;42:456–65.                                 616. Winer KK, Yanovski JA, Cutler Jr GB. Synthetic human
            596. Walters MR. Newly identified effects of the vitamin D endo-  parathyroid hormone 1-34 vs calcitriol and calcium in the
                crine system: update 1995. In: Bikle DD, Negrovilar A,  treatment of hypoparathyroidism. JAMA 1996;276:631–6.
                editors. Hormonal regulation of bone mineral metabolism.  617. Winkelmayer WC, Levin R, Avorn J. The nephrologist’s
                Bethesda: Endocrine Society; 1995. p. 47–56.         role  in  the  management  of  calcium-phosphorus
   198   199   200   201   202   203   204   205   206   207   208